Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects

Journal of Biomedical Materials Research

Volumn 35, Issue 2, 1997, Pages 181-190

  Zellin, Göran ^a   Linde, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; BONE; DEFECTS; DRUG DOSAGE; DRUG THERAPY; GROWTH KINETICS; MEDICAL APPLICATIONS;

BONE REGENERATION; GROWTH STIMULATORY IMPLANT; OSTEOPROMOTIVE MEMBRANES; RAT MANDIBULAR DEFECTS;

IMPLANTS (SURGICAL);

COLLAGEN; GROWTH FACTOR; MEMBRANE PROTEIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE REGENERATION; CONTROLLED STUDY; FRACTURE HEALING; GROWTH STIMULATION; MALE; MANDIBLE; NONHUMAN; RAT; SURGICAL ANATOMY;

EID: 0031148699     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199705)35:2<181::AID-JBM6>3.0.CO;2-J     Document Type: Article

References (32)

1. A. Linde, P. Alberius, C. Dahlin, K. Bjurstam, and Y. Sundin, "Osteopromotion. A soft tissue exclusion principle using a membrane for bone healing and bone neogenesis," J. Periodontol., 64, 1116-1128 (1993).
2. C. Dahlin, A. Linde, and H. Röckert, "Stimulation of early bone formation by the combination of an osteopromotive membrane technique and hyperbaric oxygen," Scand. J. Plast. Reconstr. Surg., 27, 103-108 (1993).
3. E. Hedner, A. Linde, and A. Nilsson, "Systemically and locally administered growth hormone stimulates bone healing in combination with osteopromotive membranes. An experimental study in rats," J. Bone Min. Res., 11, 1952-1960 (1996).
4. J. M. Wozney, V. Rosen, A. J. Celeste, L. M. Mitsock, M. J. Whitters, R. W. Kriz, R. M. Hewick, and E. A. Wang, "Novel regulators of bone formation: Molecular clones and activities," Science, 242, 1528-1534 (1988).
5. A. J. Celeste, J. A. Iannazzi, R. C. Taylor, R. M. Hewick, V. Rosen, E. A. Wang, and J. M. Wozney, "Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone," Proc. Natl. Acad. Sci., USA, 87, 9843-9847 (1990).
6. E. Ozkaynak, D. C. Rueger, E. A. Drier, C. Corbett, R. J. Ridge, T. K. Sampath, and H. Oppermann, "OP-1 cDNA encodes an osteogenic protein in the TGF-β family," EMBO J., 9, 2085-2093 (1990).
7. E. Ozkaynak, P. N. J. Schnegelsberg, D. F. Jin, G. M. Clifford, F. D. Warren, E. A. Drier, and H. Oppermann, "Osteogenic Protein-2. A new member of the transforming growth factor-β superfamily expressed early in embryogenesis," J. Biol. Chem., 267, 25220-25227 (1992).
8. E. Hedner and A. Linde, "Bone morphogenetic protein (BMP) implant in rat mandibular defects, covered by osteopromotive membranes," Eur. J. Oral Sci., 103, 236-241 (1995).
9. A. Linde and E. Hedner, "Recombinant bone morphogenetic protein enhances bone healing, guided by osteopromotive e-PTFE membranes. An experimental study in rats," Calcif. Tissue Int., 56, 549-553 (1995).
10. G. Zellin, A. Gritli-Linde, and A. Linde, "Healing of mandibular defects with different biodegradable and non-biodegradable membranes. An experimental study in rats," Biomaterials, 16, 601-609 (1995).
11. J. P. Schmitz and J. O. Hollinger, "The critical size defect as an experimental model for craniomandibulofacial nonunions," Clin. Orthop., 205, 299-308 (1986).
12. C. Dahlin, A. Linde, J. Gottlow, and S. Nyman, "Healing of bone defects by guided tissue regeneration," Plast. Reconstr. Surg., 81, 672-676 (1988).
13. E. A. Wang, V. Rosen, J. S. D'Alessandro, M. Bauduy, P. Cordes, T. Harada, D. I. Israel, R. M. Hewick, K. M. Kerns, P. LaPan, D. P. Luxenberg, D. McQuaid, I. K. Moutsatsos, J. Nove, and J. M. Wozney, "Recombinant human bone morphogenetic protein induces bone formation," Proc. Natl. Acad. Sci., USA 87, 2220-2224 (1990).
14. E. Ron, R. G. Schaub, and T. J. Turek, "Formulations of blood-clot polymer matrix for delivery of osteogenic proteins," U.S. Patent No. 5,171,579, 1992.
15. D. G. Altman, ed., Practical Statistics For Medical Research, Chapman & Hall, London, U.K., 1994, pp. 210-215.
16. E. Sandberg, C. Dahlin, and A. Linde, "Bone regeneration by the osteopromotion technique using bioabsorbable membranes: An experimental study in rats," J. Oral Maxillofac. Surg., 51, 1106-1114 (1993).
17. A. Linde, C. Thorén, C. Dahlin, and E. Sandberg, "Creation of new bone by an osteopromotive membrane technique: An experimental study in rat," J. Oral Maxillofac. Surg., 51, 892-897 (1993).
18. G. Zellin and A. Linde, "Effects of different osteopromotive membrane porosites on experimental bone neogenesis in rats," Biomaterials, 17, 695-702 (1996).
19. P. Alberius, C. Dahlin, and A. Linde, "Role of osteopromotion in experimental bone grafting to the skull: A study in adult rats using a membrane technique," J. Oral Maxillofac. Surg., 50, 829-834 (1992).
20. D. M. Toriumi, H. S. Kotler, D. P. Luxenberg, M. E. Holtrop, and E. A. Wang, "Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic and biomechanical evaluation," Arch. Otolaryngol. Head Neck Surg., 117, 1102-1112 (1991).
21. R. Kenley, L. Marden, T. Turek, L. Jin, E. Ron, and J. O. Hollinger, "Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2)," J. Biomed. Mater. Res., 28, 1139-1147 (1994).
22. L. J. Marden, J. O. Hollinger, A. Chaudhari, T. Turek, R. G. Schaub, and E. Ron, "Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats," J. Biomed. Mater. Res., 28, 1127-1138 (1994).
23. G. F. Muschler, A. Hyodo, T. Manning, H. Kambic, and K. Easley, "Evaluation of human bone morphogenetic protein 2 in a canine fusion model," Clin. Orthop. Rel. Res., 308, 229-240 (1994).
24. A. H. Reddi, "Regulation of cartilage and bone differentiation by bone morphogenetic proteins," Curr. Opin. Cell Biol., 4, 850-855 (1992).
25. V. Rosen and R. S. Thies, "The BMP proteins in bone formation and repair," Trends Genet., 8, 97-102 (1992).
26. R. A. Kenley, K. Yim, J. Abrams, E. Ron, T. Turek, L. J. Marden, and J. O. Hollinger, "Biotechnology and bone graft substitutes," Pharm. Res., 10, 1393-1401 (1993).
27. S. Miyamoto, K. Takaoka, T. Okada, H. Yoshikawa, J. Hashimoto, S. Suzuki, and K. Ono, "Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein," Clin. Orthop. Rel. Res., 278, 274-285 (1992).
28. J. O. Hollinger, "Preliminary report on the osteogenic potential of a biodegradable copolymer of polylactide (PLA) and polyglycolide (PGA)," J. Biomed. Mater. Res., 17, 71-82 (1983).
29. J. O. Hollinger and G.G. Battistone, "Biodegradable bone repair materials," Clin. Orthop. Rel. Res., 207, 290-305 (1986).
30. S. C. Lee, M. Shea, M. A. Battle, K. Kozitza, E. Ron, T. Turek, R. G. Schaub, and W. C. Hayes, "Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix," J. Biomed. Mater. Res., 28, 1149-1156 (1994).
31. T. J. Sigurdsson, M. B. Lee, K. Kubota, T. J. Turek, J. M. Wozney, and U. M. E. Wikesjö, "Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration," J. Periodont., 66, 131-138 (1995).
32. F. DeLustro, J. Dasch, J. Keefe, and L. Ellingsworth, "Immune responses to allogenic and xenogenic implants of collagen and collagen derivates," Clin. Orthop. Rel. Res., 260, 263-279 (1990).